Natural, Semi-Synthetic, and Synthetic Cannabinoids: Complete Guide 2026




Expert Guide · Herbeevor 2026

Natural, semi-synthetic and synthetic cannabinoids:
what you need to know

Behind every CBD product is a molecule whose origin — plant-derived, processed, or entirely lab-made — determines its safety profile, legality, and effectiveness. This guide provides you with the keys to understanding these differences and making an informed choice.

Natural — CBD, CBG, CBN, CBC Semi-synthetic — HHC, Delta-8, THCP Synthetic — Spice, JWH, Nabilone

Three families, three realities

Expert Guide

The CBD market has become considerably more complex since 2021. Alongside well-documented natural molecules like CBD and CBG, new substances resulting from chemical transformations have appeared — often presented as legal alternatives, rarely with the necessary transparency regarding their safety or regulatory status. Understanding how to distinguish these three families is now essential for any informed consumer.

Herbeevor Commitment: we only sell natural cannabinoids from certified European hemp. Each batch is analyzed by an independent laboratory (COA), with a THC level below 0.3% in the final product. Our traceability policy →

Natural cannabinoids

Plant-derived

Natural cannabinoids — or phytocannabinoids — are extracted directly from hemp (Cannabis sativa L.) without modification of their molecular structure. They constitute the only family of cannabinoids with a well-documented safety profile, established legality in Europe, and possible traceability from plant to finished product.

Phytocannabinoids

Directly derived from hemp, without chemical transformation

Cannabis sativa contains more than 100 distinct cannabinoids. The four main molecules available at Herbeevor — CBD, CBG, CBN, CBC — act in synergy with the plant's natural terpenes and flavonoids to produce what researchers call the entourage effect.

Why choose them
Documented safety profile — decades of clinical studies on CBD and CBG, no serious toxicity signals at usual doses.
Established legality in Europe — compliant with EU regulations as long as THC is below 0.3% in the finished product.
Entourage effect — the synergy between cannabinoids, terpenes, and flavonoids amplifies the effects of each isolated molecule.
Full traceability — from seed to capsule, every stage of production is documented and verifiable.
COA analysis compliance — each batch is subjected to independent laboratory control before being put on sale.
Acid forms — CBDA and CBGA

Before decarboxylation (the application of heat), CBD and CBG exist in the fresh plant in their acid forms — CBDA and CBGA, respectively. These precursors are the subject of promising research into their interaction with certain receptors, but remain less clinically studied than their active forms. They are present in varying concentrations in unheated Full Spectrum extracts.

The Endocannabinoid System — why these molecules work

Mechanism of action

All cannabinoid molecules — whether natural, semi-synthetic, or synthetic — interact with the endocannabinoid system (ECS), a network of receptors present throughout the human body. This system naturally regulates sleep, pain, mood, appetite, and immune response. Understanding its function helps grasp why the action profile varies so greatly from one family to another.

CB1 Receptors — central nervous system

Concentrated in the brain and spinal cord, CB1 receptors are responsible for psychoactive effects when strongly activated. THC, semi-synthetic cannabinoids like HHC, and synthetics act as direct agonists of CB1 — with highly variable intensities depending on the molecule. CBD, on the other hand, acts in a modulating and indirect way, without directly activating these receptors, which explains the absence of a psychoactive effect.

CB2 Receptors — immune system and peripheral tissues

Primarily present in the immune system, peripheral tissues, and skin, CB2 receptors are associated with anti-inflammatory effects and recovery mechanisms. CBD, CBG, and CBC preferentially interact with this pathway, contributing to their favorable safety profile. CBD topical cosmetics notably act via this cutaneous pathway, without entering systemic circulation.

CBD is not a direct agonist of CB1 or CB2 receptors. It acts primarily via allosteric mechanisms, interactions with TRPV1, 5-HT1A receptors, and other signaling pathways. It is this indirect mode of action that fundamentally distinguishes CBD from psychoactive substances — natural or synthetic. Source: Blessing et al., Neurotherapeutics (2015); Russo, British Journal of Pharmacology (2011). Herbeevor Cannabinoids Guide →

Semi-synthetic cannabinoids

Caution required

Semi-synthetic cannabinoids are produced in the laboratory from a natural cannabinoid — generally CBD — which undergoes one or more chemical transformations to modify its molecular structure and create a new substance with different effects. This process is legal in some cases, but the regulatory status of these molecules is evolving rapidly in France and Europe.

Between nature and chemistry

Obtained by chemical transformation of a natural cannabinoid

Their common point: a plant-derived starting molecule (CBD or THC) modified by hydrogenation, isomerization, or alkyl chain elongation. The resulting effects can radically differ from the original molecule.

Main points of concern
Unstable legal status — France has classified several of these molecules as narcotics since 2023, and other European regulations are being harmonized.
Limited safety data — few or no published clinical trials on long-term effects. Available studies are predominantly preclinical.
Risk of chemical residues — if the transformation process is poorly controlled, solvents or reagents can contaminate the final product.
Possible psychoactive effects — some molecules (Delta-8 THC, THCP) significantly activate CB1 receptors, with effects similar to THC.
Absence of entourage effect — isolated molecules, without the synergy of terpenes and natural cannabinoids from hemp.
Most common molecules
HHC
Hexahydrocannabinol Obtained by hydrogenation of THC or CBD. Moderate to intense psychoactive effects depending on the dose. Prohibited in France since the decree of June 13, 2023. Illegal in France
Delta-8
Delta-8 THC Isomer of Delta-9 THC obtained by isomerization of CBD. Psychoactive effects lighter than Delta-9. Legal status varies depending on European countries. Uncertain status in EU
THCP
Tetrahydrocannabiphorol Analog of THC with an elongated alkyl chain. Very high affinity for CB1 receptors — powerful and unpredictable effects. Very few studies available. Not authorized in France
Delta-10
Delta-10 THC Another isomer of THC produced in the laboratory. Clinical data almost nonexistent. Frequent presence of contaminants reported in independent analyses. Insufficient data

Legal Point France 2026: HHC, HHCP and their derivatives have been classified as narcotics by ministerial decree since June 2023. Their sale, possession, and use are subject to criminal prosecution in French territory, regardless of the product's country of manufacture. Consult the CBD legality guide 2026 →

Synthetic cannabinoids

Proven danger

Synthetic cannabinoids are entirely manufactured by chemical synthesis, without any plant raw material. They mimic the action of natural cannabinoids on endocannabinoid receptors, but with an affinity often 10 to 100 times higher for CB1 receptors — making their effects unpredictable, potentially serious, and very different from the classic CBD experience.

No plant origin

Entirely lab-made — without plant raw material

Their only commonality with natural CBD is their ability to interact with cannabinoid receptors. For everything else — safety, legality, predictability of effects — they constitute a radically distinct category that all CBD consumers must be aware of to avoid confusion.

Why absolutely avoid them (outside of supervised medical use)
No safety data for non-medical use. No clinical trials, no established tolerance profile.
Extreme CB1 affinity — some molecules (JWH-018, AM-2201) are up to 100 times more potent than natural THC on CB1 receptors.
Illegal throughout the EU for any non-medical use, classified as narcotics or narcotic analogues.
Documented cardiovascular, neurological and psychiatric risks: seizures, arrhythmias, psychotic episodes, hospitalizations.
No traceability — actual composition often unknown even to sellers, massive variations in concentration from batch to batch.
Examples to know
Spice / K2
Synthetic cannabinoid blends Sprayed on neutral plants. Extremely dangerous, responsible for hundreds of hospitalizations in Europe every year. Totally illegal throughout the EU.
JWH-018
Synthetic research cannabinoid Potent agonist of CB1 receptors. Unpredictable and potentially lethal effects at high doses. Classified as a narcotic throughout the EU.
Nabilone
Medical cannabinoid (strictly controlled use) Medical exception prescribed for chemotherapy-related nausea. Exclusively for hospital use under medical prescription — not an alternative to CBD.

Warning: synthetic cannabinoids are sometimes presented online as legal substitutes for cannabis or CBD. This is neither legally nor scientifically accurate. Their acquisition, possession, and use expose individuals to serious criminal risks and documented health hazards. They have no connection to the legal CBD universe.

Comparison Table — The Three Families

Summary

A direct comparison of essential criteria to evaluate each cannabinoid family: legality, safety, entourage effect, and traceability.

Criterion Natural (CBD, CBG, CBN, CBC) Semi-synthetic (HHC, Delta-8…) Synthetic (Spice, JWH…)
Origin Hemp plant (Cannabis sativa) Chemically transformed CBD or THC Total chemical synthesis, no plant origin
EU Legality (2026) Legal (THC < 0.3%) Variable — often prohibited Illegal outside medical use
French Legality Compliant HHC banned since 2023 Narcotics
Safety Data Well-documented Limited Insufficient / dangerous
Entourage Effect Yes (Full Spectrum) No No
Traceability Plant → product (COA) Partial None
Psychoactivity No (CBD, CBG, CBN, CBC) Possible to probable Yes, often intense
Available at Herbeevor Yes — full range No No

Which natural molecule to choose according to your objective?

Herbeevor Recommendations

Staying within the framework of natural cannabinoids – the only legal, safe and traceable ones – each comfort objective corresponds to one or two priority molecules. Here are the associations we recommend at Herbeevor.

Drivers: Full Spectrum products containing up to 0.3% legal THC can trigger a positive saliva test. It is essential to choose a certified Broad Spectrum format with 0% detectable THC — capsules, Broad Spectrum oil, or CBD e-liquids. CBD legality and driving guide →

Legal Framework in France — What Changes in 2026

Update 2026

French regulations concerning cannabinoids have seen several significant developments since 2021. Here are the essential points to know for buying and consuming legally.

What is legal, what is prohibited

Natural CBD (Full Spectrum, THC < 0.3%): legal for sale, possession, and consumption in France. Hemp flowers and leaves are also permitted since the repeal of the ban decree, provided a compliant THC level. Flower legality details →
Broad Spectrum CBD (0% detectable THC): legal and recommended for individuals with specific constraints — drivers, athletes subject to anti-doping controls, professionals in regulated environments.
HHC, HHCP and derivatives: classified as narcotics by decree of June 13, 2023. Sale, possession, and use are illegal in France, regardless of concentration or country of origin.
Synthetic cannabinoids (Spice, JWH, etc.): classified as narcotics throughout the European Union. No derogation possible except for strictly controlled medical prescription.
Saliva test and Full Spectrum: a THC level below 0.3% remains legal, but can generate a positive result during a roadside check. The driver's criminal liability can be engaged regardless of the legality of the consumed product. Drivers must choose a certified Broad Spectrum format.

Herbeevor Guarantees

Certified · Traced · 100% Natural

Only natural cannabinoids, analyzed batch by batch.

Herbeevor does not market any semi-synthetic or synthetic substances. Our entire range comes from legal Cannabis sativa varieties, grown in Europe, with a THC level below 0.3% on the finished product, attested by an independent laboratory analysis certificate (COA) available on each product sheet.

Batch COA Analyses Independent third-party lab report accessible on each product page
THC < 0.3% Proven French legal threshold respected — documented, not just declared
Full Traceability From seed to finished product — documented plant origin and production chain
Zero Medical Claims 100% compliant communication — comfort, balance, well-being only

All Herbeevor Resources



Natural, traceable, certified cannabinoids.

COA analysis available · THC < 0.3% proven · 100% natural · Fast and discreet delivery
No semi-synthetic or synthetic cannabinoids in our range.

Secure payment · Expert CBD advice · Legal compliance France 2026

Anmeldung

Haben Sie Ihr Passwort vergessen?

Sie haben noch kein Konto?
Konto erstellen